Lumexa Imaging Holdings, Inc. LMRI R2K
Healthcare · Medical Devices · United States
Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. The company provides outpatient medical imaging services, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET) services, as well as X-ray, ultrasound, and mammography diagnostic and screening imaging services. Lumexa Imaging Holdings, Inc. was founded in 2018 and is based in Raleigh, North Carolina.
READ MORE ›$7.78
-57.99% 1Y
Market & Price
Market Cap
$747.51M
Current Price
$7.78
High / Low (52W)
$18.53 / $6.77
Beta
-
Valuation
Stock P/E
-
Industry PE
23.65
Forward P/E
8.70
PEG Ratio
-
Book Value
$6.10
Price to Book
1.28
P/S
0.73
EV/EBITDA
19.40
Dividend Yield
-
Profitability & Returns
ROCE
5.44%
ROE
-
ROA
-
Profit Margin
-3.66%
Op Margin
3.51%
EPS (Latest Qtr)
$0.02
EPS (TTM)
$-0.39
Balance Sheet & Liquidity
Debt/Equity
1.61
Quick Ratio
1.30
Current Ratio
1.41
Debt
$967.45M
Total Assets
$1.76B
Current Assets
$227.26M
Working Capital
$48.07M
Ownership
Promoter Holding
81.10%
Chg in Prom Hold
-
FII / Inst Holding
34.48%
Chg in FII Hold
-
Financial Snapshot
Enterprise Value
$1.66B
Total Revenue (TTM)
$1.03B
EBITDA
$85.77M
Free Cash Flow
-
Operating Cash Flow
$33.97M
Shares Outstanding
96.08M
Gross Margin
15.06%
Payout Ratio
0.00%
Growth (CAGR)
Revenue 5Y
4.55%
Profit 5Y
30.73%
Revenue (YoY)
3.10%
Earnings (YoY)
-
PROS
- Profit CAGR of 30.7% over 5 years.
CONS
- Trading 58.0% below its 52-week high.
* The pros and cons are auto-generated from financial metrics.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth
No fundamental data available for this stock.
Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).
Peer comparison
Peer companies in the same sector (Healthcare).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | LMRI Lumexa Imaging Holdings, Inc. R2K | 7.78 | - | $747.51M | - | 5.44% | - | 4.55% | 30.73% |
| 2 | LLY Eli Lilly and Company SPX | 1,105.00 | 39.21 | $985.37B | 0.63% | 38.44% | 107.46% | 31.69% | 48.96% |
| 3 | JNJ Johnson & Johnson SPX | 225.33 | 26.11 | $542.42B | 2.38% | 23.13% | 26.42% | 5.60% | 14.32% |
| 4 | UNH UnitedHealth Group Incorporated SPX | 380.31 | 28.66 | $345.38B | 2.32% | 9.60% | 12.18% | 11.35% | -15.69% |
| 5 | MRK Merck & Co., Inc. SPX | 118.72 | 33.44 | $293.22B | 2.86% | 20.66% | 18.94% | 3.12% | 7.93% |
| 6 | TMO Thermo Fisher Scientific Inc. SPX | 492.51 | 27.11 | $183.03B | 0.38% | 9.17% | 13.52% | -0.27% | -1.19% |
| 7 | AMGN Amgen Inc. NDXSPX | 336.79 | 23.42 | $181.77B | 2.99% | 18.02% | 101.32% | 11.77% | 5.58% |
| 8 | GILD Gilead Sciences, Inc. NDXSPX | 134.43 | 18.29 | $166.90B | 2.44% | 22.92% | 43.36% | 2.57% | 22.83% |
| 9 | ISRG Intuitive Surgical, Inc. NDXSPXAI | 424.64 | 51.53 | $150.39B | - | 15.96% | 17.23% | 17.39% | 29.26% |
Ad space
Quarterly Results
Figures in USD.
| Metric | Dec 2024 | Mar 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|
| Revenue | 248.03M | 245.00M | 267.73M | 252.54M |
| Cost of Revenue | 226.46M | 208.40M | 225.62M | 217.75M |
| Gross Profit | 21.57M | 36.60M | 42.12M | 34.78M |
| Operating Expenses | 29.97M | 26.54M | 49.59M | 30.26M |
| Operating Income | -8.40M | 10.06M | -7.47M | 4.53M |
| EBITDA | 28.94M | 38.33M | 19.00M | 33.29M |
| Interest Expense | 31.39M | 29.85M | 28.02M | 16.33M |
| Pretax Income | -16.03M | -4.31M | -25.26M | 3.08M |
| Tax Provision | 9.03M | 3.38M | 3.43M | 1.36M |
| Net Income | -25.06M | -7.69M | -28.69M | 1.72M |
| Diluted EPS | - | -0.08 | -0.38 | 0.02 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Revenue | 935.92M | 948.87M | 1.02B |
| Cost of Revenue | 836.96M | 852.61M | 865.52M |
| Gross Profit | 98.97M | 96.26M | 157.56M |
| Operating Expenses | 111.80M | 112.53M | 130.83M |
| Operating Income | -12.83M | -16.26M | 26.73M |
| EBITDA | 94.51M | 113.96M | 141.71M |
| Interest Expense | 141.69M | 136.03M | 118.54M |
| Pretax Income | -119.25M | -79.19M | -32.22M |
| Tax Provision | 2.98M | 14.91M | 14.88M |
| Net Income | -122.23M | -94.10M | -47.10M |
| Diluted EPS | -1.76 | -1.35 | -0.66 |
Compounded Sales Growth
| 5 Years: | 4.55% |
| 1 Year: | 3.10% |
Compounded Profit Growth
| 5 Years: | 30.73% |
| 1 Year: | - |
Stock Price Performance
| 1 Year: | -57.99% |
| 6 Months: | - |
| 3 Months: | -44.98% |
| 1 Month: | -16.97% |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Total Assets | 1.67B | 1.67B | 1.76B |
| Current Assets | 166.77M | 172.52M | 227.26M |
| Cash & Equivalents | 20.19M | 26.13M | 58.83M |
| Inventory | - | - | - |
| Receivables | 124.12M | 130.35M | 131.84M |
| Total Liabilities | 1.47B | 1.51B | 1.18B |
| Current Liabilities | 161.12M | 173.66M | 179.19M |
| Long Term Debt | 1.18B | 1.19B | 819.03M |
| Total Debt | 1.30B | 1.31B | 962.50M |
| Total Equity | 198.43M | 161.65M | 586.12M |
| Shares Outstanding | 94.57M | 94.57M | 96.11M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Operating Cash Flow | 37.51M | 40.73M | 17.07M |
| Investing Cash Flow | -29.66M | -22.28M | -20.96M |
| Financing Cash Flow | -8.77M | -12.50M | 36.58M |
| Capital Expenditure | -24.01M | -27.77M | -23.48M |
| Free Cash Flow | 13.51M | 12.95M | -6.40M |
| Net Change in Cash | -912.00K | 5.95M | 32.70M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Gross Margin % | 10.6% | 10.1% | 15.4% |
| Operating Margin % | -1.4% | -1.7% | 2.6% |
| Net Margin % | -13.1% | -9.9% | -4.6% |
| ROE % | -61.6% | -58.2% | -8.0% |
| ROCE % | -0.8% | -1.1% | 1.7% |
Shareholding Pattern
Insiders
81.10%
Institutions
34.48%
Public Float
182.45%
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Alliancebernstein L.P. | 3.10% | 2.98M | $23.19M |
| 2 | Massachusetts Financial Services Co. | 2.43% | 2.33M | $18.16M |
| 3 | Janus Henderson Group PLC | 2.19% | 2.10M | $16.34M |
| 4 | Brown Advisory Inc. | 1.77% | 1.71M | $13.27M |
| 5 | ArrowMark Colorado Holdings LLC | 1.72% | 1.65M | $12.86M |
| 6 | Blackrock Inc. | 1.59% | 1.53M | $11.87M |
| 7 | Invesco Ltd. | 1.50% | 1.44M | $11.21M |
| 8 | Healthcare of Ontario Pension Plan Trust Fund | 1.35% | 1.30M | $10.11M |
| 9 | JPMORGAN CHASE & CO | 1.15% | 1.10M | $8.59M |
| 10 | Vanguard Capital Management LLC | 1.10% | 1.06M | $8.24M |
Analyst View
Loading analyst coverage…
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for LMRI
No recent headlines available.